Circulation. 2005;111:1184-1191
doi: 10.1161/01.CIR.0000157156.85397.A1
(Circulation. 2005;111:1184-1191.)
© 2005 American Heart Association, Inc.
p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells
Florian H. Seeger, MD;
Judith Haendeler, PhD;
Dirk H. Walter, MD;
Ulrich Rochwalsky;
Johannes Reinhold, BSc;
Carmen Urbich, PhD;
Lothar Rössig, MD;
Anne Corbaz, PhD;
Yolande Chvatchko, PhD;
Andreas M. Zeiher, MD;
Stefanie Dimmeler, PhD
From Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Theodor-Stern-Kai 7, Frankfurt, Germany (F.H.S., J.H., D.H.W., U.R., J.R., C.U., L.R., A.M.Z., S.D.), and Serono Pharmaceutical Research Institute, Geneva, Switzerland (A.C., Y.C.).
Correspondence to Stefanie Dimmeler, PhD, Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Theodor Stern-Kai 7, 60590 Frankfurt, Germany. E-mail dimmeler{at}em.uni-frankfurt.de
Received July 27, 2004; revision received October 26, 2004; accepted November 3, 2004.
Background— Transplantation of endothelial progenitor cells (EPCs) improves neovascularization after ischemia, but patients with coronary artery disease (CAD) or diabetes mellitus show a reduced number of EPCs and impaired functional activity. Therefore, we investigated the effects of risk factors, such as glucose and TNF-
, on the number of EPCs in vitro to elucidate the underlying mechanisms.
Methods and Results— EPCs of patients or healthy subjects were isolated from peripheral blood. Incubation with glucose or TNF- dose-dependently reduced the number of EPCs (79.9±1.3% and 74.3±8.1% of control; P<0.05, respectively). This reduction was not caused by apoptosis. TNF- and glucose induced a dose- and time-dependent activation of the p38 MAP kinase, the downstream kinase mitogen- and stress-activated kinase 1, and the transcription factor cAMP-responsive element–binding protein (CREB), in EPCs. Moreover, EPCs from CAD patients had significantly higher basal p38-phosphorylation levels (1.83±0.2-fold increase; P<0.05) compared with healthy subjects. The inhibition of the p38-kinase by SB203580 or infection with a dominant negative p38 kinase adenovirus significantly increased basal number of EPCs (136.7±6.3% and 142.9±18% versus control, respectively). Likewise, ex vivo cultivation of EPCs from patients with CAD with SB203580 significantly increased the number of EPCs and partially reversed the impaired capacity for neovascularization of EPCs in vivo (relative blood flow: 0.40±0.03 versus 0.64±0.08, P<0.05). The increased numbers of EPCs by SB203580 were associated with an augmentation of EPC proliferation and a reduction of cells expressing the monocytic marker proteins CD14 and CD64, suggesting that p38 regulates proliferation and differentiation events.
Conclusions— These results demonstrate that p38 MAP kinase plays a pivotal role in the signal transduction pathways regulating the number of EPCs ex vivo. SB203580 can prevent the negative effects of TNF- and glucose on the number of EPCs and may be useful to improve the number of EPCs for potential cell therapy.
Key Words: angiogenesis • glucose • mitogen-activated protein kinases • stem cells • tumor necrosis factor-
This article has been cited by other articles:
|
|
|
|
 
V. Tchaikovski, S. Olieslagers, F.-D. Bohmer, and J. Waltenberger
Diabetes Mellitus Activates Signal Transduction Pathways Resulting in Vascular Endothelial Growth Factor Resistance of Human Monocytes
Circulation,
July 14, 2009;
120(2):
150 - 159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Leroyer, T. G. Ebrahimian, C. Cochain, A. Recalde, O. Blanc-Brude, B. Mees, J. Vilar, A. Tedgui, B. I. Levy, G. Chimini, et al.
Microparticles From Ischemic Muscle Promotes Postnatal Vasculogenesis
Circulation,
June 2, 2009;
119(21):
2808 - 2817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Tian, P. H. Liang, and L.-Y. Li
Inhibition of endothelial progenitor cell differentiation by VEGI
Blood,
May 21, 2009;
113(21):
5352 - 5360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, B.-S. Herbert, G. Rajashekhar, D. A. Ingram, M. C. Yoder, M. Clauss, and J. Rehman
Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-{alpha} via the p38 mitogen-activated protein kinase pathway
FASEB J,
May 1, 2009;
23(5):
1358 - 1365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nakamura, M. Kimura, C. Goto, K. Noma, M. Yoshizumi, K. Chayama, Y. Kihara, and Y. Higashi
Cigarette Smoking Abolishes Ischemic Preconditioning-Induced Augmentation of Endothelium-Dependent Vasodilation
Hypertension,
April 1, 2009;
53(4):
674 - 681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Salvatore, A. Casamassimi, L. Sommese, C. Fiorito, A. Ciccodicola, R. Rossiello, B. Avallone, V. Grimaldi, V. Costa, M. Rienzo, et al.
Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells
PNAS,
July 8, 2008;
105(27):
9427 - 9432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al.
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
Circulation,
June 10, 2008;
117(23):
3020 - 3030.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dimmeler and A. Leri
Aging and Disease as Modifiers of Efficacy of Cell Therapy
Circ. Res.,
June 6, 2008;
102(11):
1319 - 1330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Zhang, X.-H. Wang, S.-F. Chen, G.-P. Zhang, N. Lu, R.-M. Hu, and H.-M. Jin
Biphasic response of endothelial progenitor cell proliferation induced by high glucose and its relationship with reactive oxygen species
J. Endocrinol.,
June 1, 2008;
197(3):
463 - 470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Balestrieri, C. Schiano, F. Felice, A. Casamassimi, A. Balestrieri, L. Milone, L. Servillo, and C. Napoli
Effect of Low Doses of Red Wine and Pure Resveratrol on Circulating Endothelial Progenitor Cells
J. Biochem.,
February 1, 2008;
143(2):
179 - 186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Grisar, D. Aletaha, C. W Steiner, T. Kapral, S. Steiner, M. Saemann, I. Schwarzinger, B. Buranyi, G. Steiner, and J. S Smolen
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy
Ann Rheum Dis,
October 1, 2007;
66(10):
1284 - 1288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Sorrentino, F. H. Bahlmann, C. Besler, M. Muller, S. Schulz, N. Kirchhoff, C. Doerries, T. Horvath, A. Limbourg, F. Limbourg, et al.
Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone
Circulation,
July 10, 2007;
116(2):
163 - 173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M Cubbon, A. Rajwani, and S. B Wheatcroft
The impact of insulin resistance on endothelial function, progenitor cells and repair
Diabetes and Vascular Disease Research,
June 1, 2007;
4(2):
103 - 111.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y.-H. Chen, S.-J. Lin, F.-Y. Lin, T.-C. Wu, C.-R. Tsao, P.-H. Huang, P.-L. Liu, Y.-L. Chen, and J.-W. Chen
High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide-Related but Not Oxidative Stress-Mediated Mechanisms
Diabetes,
June 1, 2007;
56(6):
1559 - 1568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro
Significance of Endothelial Progenitor Cells in Subjects With Diabetes
Diabetes Care,
May 1, 2007;
30(5):
1305 - 1313.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Casamassimi, M. L. Balestrieri, C. Fiorito, C. Schiano, C. Maione, R. Rossiello, V. Grimaldi, V. Del Giudice, C. Balestrieri, B. Farzati, et al.
Comparison Between Total Endothelial Progenitor Cell Isolation Versus Enriched Cd133+ Culture
J. Biochem.,
April 1, 2007;
141(4):
503 - 511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Thum, D. Fraccarollo, M. Schultheiss, S. Froese, P. Galuppo, J. D. Widder, D. Tsikas, G. Ertl, and J. Bauersachs
Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes
Diabetes,
March 1, 2007;
56(3):
666 - 674.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Li, J. A. Deane, N. V. Campanale, J. F. Bertram, and S. D. Ricardo
Blockade of p38 Mitogen-Activated Protein Kinase and TGF-beta1/Smad Signaling Pathways Rescues Bone Marrow-Derived Peritubular Capillary Endothelial Cells in Adriamycin-Induced Nephrosis
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2799 - 2811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Marumo, H. Uchimura, M. Hayashi, K. Hishikawa, and T. Fujita
Aldosterone Impairs Bone Marrow-Derived Progenitor Cell Formation
Hypertension,
September 1, 2006;
48(3):
490 - 496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Marchetti, R. Menghini, S. Rizza, A. Vivanti, T. Feccia, D. Lauro, A. Fukamizu, R. Lauro, and M. Federici
Benfotiamine Counteracts Glucose Toxicity Effects on Endothelial Progenitor Cell Differentiation via Akt/FoxO Signaling.
Diabetes,
August 1, 2006;
55(8):
2231 - 2237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. G Ebrahimian, C. Heymes, D. You, O. Blanc-Brude, B. Mees, L. Waeckel, M. Duriez, J. Vilar, R. P. Brandes, B. I. Levy, et al.
NADPH Oxidase-Derived Overproduction of Reactive Oxygen Species Impairs Postischemic Neovascularization in Mice with Type 1 Diabetes
Am. J. Pathol.,
August 1, 2006;
169(2):
719 - 728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Kanaganayagam and M. S. Marber
ADMAring Endothelial Progenitor Cells: Accident, Association, or Antecedent
J. Am. Coll. Cardiol.,
November 1, 2005;
46(9):
1702 - 1704.
[Full Text]
[PDF]
|
|
|
